Explore more publications!
Martinique Science Reporter
Got News to Share?

Martinique Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Martinique Science Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 23, 2025

Genius Group Announces 25% Increase in Revenue on proforma basis, 57% Decrease in Net Loss per Share in First Half of 2025
September 23, 2025

Genius Group Announces 25% Increase in Revenue on proforma basis, 57% Decrease in Net Loss per Share in First Half of 2025

Indeterminate GlobeNewswire
Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech
September 23, 2025

Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech

Indeterminate GlobeNewswire
Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis
September 23, 2025

Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis

Indeterminate GlobeNewswire
ZenaTech Closes Tenth Acquisition of A&J Land Surveyor Inc., Expanding Drone as a Service (DaaS) to Florida’s Aviation, Utility, and Infrastructure Markets
September 23, 2025

ZenaTech Closes Tenth Acquisition of A&J Land Surveyor Inc., Expanding Drone as a Service (DaaS) to Florida’s Aviation, Utility, and Infrastructure Markets

Indeterminate GlobeNewswire
Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025
September 23, 2025

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

Indeterminate GlobeNewswire
Altimmune to Participate in Two Upcoming Investor Conferences
September 23, 2025

Altimmune to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
reAlpha Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement
September 23, 2025

reAlpha Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement

Indeterminate GlobeNewswire
ZenaTech cierra su décima adquisición de A&J Inc., expandiendo Drone como Servicio (DaaS) a los mercados de aviación, servicios públicos e infraestructura de Florida
September 23, 2025

ZenaTech cierra su décima adquisición de A&J Inc., expandiendo Drone como Servicio (DaaS) a los mercados de aviación, servicios públicos e infraestructura de Florida

Indeterminate GlobeNewswire
Crane NXT Expects High Single Digit Revenue Growth in its U.S. Currency Business in 2026
September 23, 2025

Crane NXT Expects High Single Digit Revenue Growth in its U.S. Currency Business in 2026

Indeterminate GlobeNewswire
Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22
September 23, 2025

Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22

Indeterminate GlobeNewswire
Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA
September 23, 2025

Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA

Indeterminate GlobeNewswire
Symbotic and Nyobolt Announce New Performance-Improving Power Technology for SymBot™ Autonomous Mobile Robots
September 23, 2025

Symbotic and Nyobolt Announce New Performance-Improving Power Technology for SymBot™ Autonomous Mobile Robots

Indeterminate GlobeNewswire
Calian Launches Canada’s First Defence Innovation Orchestrator to Scale Small to Mid-Sized Enterprise
September 23, 2025

Calian Launches Canada’s First Defence Innovation Orchestrator to Scale Small to Mid-Sized Enterprise

Indeterminate GlobeNewswire
BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer
September 23, 2025

BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer

Indeterminate GlobeNewswire
Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway
September 23, 2025

Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway

Indeterminate GlobeNewswire
Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup
September 23, 2025

Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup

Indeterminate GlobeNewswire
Trident Reports First Half 2025 Unaudited Financial Results
September 23, 2025

Trident Reports First Half 2025 Unaudited Financial Results

Indeterminate GlobeNewswire
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
September 23, 2025

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

Indeterminate GlobeNewswire
Nano Labs Ltd Announces Uplisting to The Nasdaq Global Market
September 23, 2025

Nano Labs Ltd Announces Uplisting to The Nasdaq Global Market

Indeterminate GlobeNewswire
BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“
September 23, 2025

BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions